Randomized Trial Investigating Melatonin Supplementation vs Placebo on Sleep Disturbance Following Total Joint Arthroplasty
Not Applicable
- Conditions
- Sleep DisturbanceTotal Joint Arthroplasty
- Interventions
- Drug: Placebo
- Registration Number
- NCT04590742
- Lead Sponsor
- Rothman Institute Orthopaedics
- Brief Summary
The purpose of this study is to determine whether melatonin when used as a supplement after surgery improves sleep following total joint arthroplasty
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 154
Inclusion Criteria
- Patients who undergo unilateral primary total joint arthroplasty
- Patient willing and able to complete postoperative surveys
Exclusion Criteria
- Patients who undergo revision total joint arthroplasty
- Patients who undergo bilateral total joint arthroplasty
- Patients currently taking melatonin supplementation
- Patient has history of substance abuse (drug or alcohol)
- Patient is a workman's comp patient or patient has current litigation pending
- Patient has an allergy to melatonin
- Patient has a history of delirium/psychiatric/depression/on antidepressants
- Patient has a history of insomnia/ on sleep aid medication
- Anyone on warfarin
- Sleep apnea
- Patient discharged to SNF or rehab
- Patients who have inflammatory conditions
- Shift work or night work
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group 1 Placebo Placebo Tablet Group 2 melatonin 6mg Melatonin (6mg)
- Primary Outcome Measures
Name Time Method Patient Sleep Quality 6 weeks Patients quality of sleep will be analyzed by having them answer a sleep quality index (PSQI) questionnaires
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Rothman Orthopaedic Institute
🇺🇸Philadelphia, Pennsylvania, United States